Dow Up2.00% Nasdaq Up1.66%

Haemonetics Corporation (HAE)

31.82 Up 0.60(1.92%) Feb 12, 4:02PM EST
|After Hours : 31.82 0.00 (0.00%) Feb 12, 4:33PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.6
Mean Recommendation (last week):2.6

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:36.33
Median Target:35.00
High Target:44.00
Low Target:29.00
No. of Brokers:9

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Nov 23, 2015Raymond JamesDowngradeMkt PerformUnderperform
Jul 28, 2015Barrington ResearchUpgradeMkt PerformOutperform
Apr 28, 2015Barrington ResearchDowngradeOutperformMkt Perform
Dec 31, 2013The Benchmark CompanyDowngradeBuyHold
Jun 5, 2013William BlairInitiated Outperform
Sep 13, 2012The Benchmark CompanyInitiated Buy
Aug 3, 2011Barrington ResearchUpgradeMkt PerformOutperform
Jul 29, 2011Morgan KeeganDowngradeOutperformMkt Perform
Apr 4, 2011Barrington ResearchDowngradeOutperformMkt Perform
Jan 6, 2010Barrington ResearchInitiated Outperform

More Upgrades & Downgrades for HAE

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3333

Data provided by Thomson/First Call

Currency in USD.